CXCL5 induces an aggravated pro-inflammatory environment early in VaD, which can acutely recruit neutrophils and leukocytes at the site of damage, which in turn leads to microvascular dysfunction and disruption of the blood-brain barrier, further aggravating cerebral ischemia. Here, CXCL5 is linked to Cerebral ischemia.